I.. Introduction {#sec1}
================

The accurate detection of cancer is a challenging task. According to the Centers of Disease Control and Prevention (CDC), breast cancer is the most prevalent cancer in women and in 2013 accounted for 230,815 women and 2,109 men being diagnosed with breast cancer [@ref1]. We implement a cascaded neural network cancer classification algorithm based solely on utilizing statistical variation and central tendency information between malignant and benign breast tissue impedance data as input to the neural network.

NovaScan Inc. has developed a portable noninvasive device that successfully characterizes benign versus malignant tissue based on an analysis of the frequency sampled impedance data collected [@ref2]. That analysis is based on one of the four parameters in the Cole-Cole model, *fc*, the relaxation or characteristic frequency of the least squares fit to the impedance data [@ref3], [@ref4]. The fitting parameter R~0~ (ohms) is low frequency resistance, $\documentclass[12pt]{minimal}
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\end{document}$ has a real (resistive) component, Z' and an imaginary (reactive) component Z". The model is embodied in [(1)](#deqn1){ref-type="disp-formula"}.$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}\begin{equation*} Z^{\ast }= Z^{'}+ Z^{"}= \frac {R_{0}-R_{\infty }}{1+\left ({ j\frac {f}{f_{c}} }\right )}+R_{\infty } \end{equation*}\end{document}$$ Cole and Cole [@ref3], [@ref4] credited with the development of [(1)](#deqn1){ref-type="disp-formula"} is most noted for his contribution to biophysics, however, his earlier work also included collaborations with [@ref5], [@ref6] that describe the voltage-current relationship of living cell membranes. The effort of [@ref7] expanded this effort to "obtain simultaneous measurements, in some simple artificial systems, of the electrical properties mentioned and to modify and extend the kinetic theory of ion motion to cover the observed phenomena to the extent that they may be physical rather than metabolic." A significant physiological characterization related to the Cole model is called the equilibrium or reverse potential. It is the value of transmembrane voltage where the movement of ions and electrical activity exist such that there is no net ion flow across the membrane. The equilibrium potential for any ion can be calculated using the Nernst equation [@ref7] depicted in [(2)](#deqn2){ref-type="disp-formula"}. Nernst [@ref7] attributes this phenomenon as the membrane being in thermodynamic equilibrium where there is no net flux ($\documentclass[12pt]{minimal}
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\end{document}$ is the membrane potential (in volts or joules/coulomb), \[ion\]~outside~ is the extracellular ion concentration in (moles/m^3^), \[ion\]~inside~ is the intracellular ion concentration in (moles/m^3^), $\documentclass[12pt]{minimal}
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\end{document}$ is Faraday's constant in (coulombs/mole), z is the number of electrons transferred in the reaction.

The model in [(2)](#deqn2){ref-type="disp-formula"} is valid when expressing one specific ion, however since various ion channels and transport mechanisms provide varying permeability to distinct ions such as Na^+^, K^+^, Ca^2+^, and Cl^−^, a voltage differential exists between the intracellular cytoplasm and extracellular space. This potential difference, *Vm*, is the membrane potential [@ref8]. A cell is considered depolarized when *Vm* is less negative and depolarized due to conductance charges, or 1/*Z '*in relationship to the Cole model in [(1)](#deqn1){ref-type="disp-formula"}. A model that encompasses varying ionic conductance and takes into account multiple ions is the model equation in [(3)](#deqn3){ref-type="disp-formula"} developed by [@ref9] and [@ref10].$$\documentclass[12pt]{minimal}
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}{}\begin{equation*} V_{m}= \frac {RT}{F} ln \frac {P_{Na^{+}}[{Na^{+}]}_{o }+P_{K^{+}}[{Na^{+}]}_{o }+P_{Cl^{-}}[{Cl^{-}]}_{o}}{P_{Na^{+}}[{Na^{+}]}_{i }+P_{K^{+}}[{Na^{+}]}_{i }+P_{Cl^{-}}[{Cl^{-}]}_{i}} \end{equation*}\end{document}$$ It is well established that cancer cells possess bioelectrical properties distinctly different than normal cells and electrophysiological analysis in cancer cell types report a depolarized *Vm* that contributes to cellular proliferation and migration. Recent research suggests that *Vm* has a functional role in cancer migration [@ref8].

[Figure 1](#fig1){ref-type="fig"} displays a list of *Vm* values gathered by and provided courtesy of the authors in [@ref8]. FIGURE 1.Vm (mV) for various tissue types provided courtesy of [@ref8].

We can now calculate the Nernst equation for generally accepted values of transmembrane ionic K^+^, where $\documentclass[12pt]{minimal}
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\end{document}$ (mM) to calculate *Vm,* which is approximately −70mV. If we now vary the range of K^+^ inside and outside the cell, we can depict depolarized *Vm* and its relationship to malignancy and the correlation to the Cole relaxation frequency, *fc*, [Fig 2](#fig2){ref-type="fig"}. FIGURE 2.Nernst calculation for K^+^ depicting depolarized *Vm* and the resulting Fcole, *fc*, probabilities.

The data used in this work were collected in an IRB approved study at two different Aurora Medical Center facilities in Milwaukee, WI. The database consisted of 232 histologically confirmed malignant and 191 benign excised breast tissue patient impedance files consisting of 47 frequency samples in the range, 1 Hz -- 32 MHz. Statistics reported in a publication of the results from that study [@ref2] indicated sensitivity of 100% and specificity of 85%. Erroneous false positive (FP) or false negative (FN) results can lead to over diagnosis or under diagnoses respectively. Screening mammograms can account for about a 20% false negative rate [@ref11]. The analysis reported in [@ref2] reduced the FN rate compared with screening mammography to 0%; however, the goal of this endeavor is to further reduce the FP rate of 15%.

II.. Methods and Procedures {#sec2}
===========================

The raw impedance based files utilized to implement the multiple neural network classification schemes were collected from a previous study database [@ref2]. The device developed by Novascan used to collect impedance data from excised tissue samples were: a symmetric planar four electrode sensor array consisting of silver/silver chloride (Ag/AgCl) or blackened platinum (BPt) with each electrode measuring 5 mm long by 0.5 mm wide separated by 0.5 mm spacing. The outer electrodes serve to apply current while the inner electrodes sense the resulting specimen voltage. Applying Ohm's Law, impedance ($\documentclass[12pt]{minimal}
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\end{document}$ voltage (V)/current (I) provides the measured complex impedance based on a fixed complex applied alternating current voltage and known current. The device and electrode circuitry is optically connected to a laptop computer which stores the real ($\documentclass[12pt]{minimal}
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\end{document}$ from 1 Hz -- 32 MHz. The laptop also provides a graphical user interface to monitor the $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${Z}^\ast $
\end{document}$ components and view the final Cole analysis result. A local regression non-parametric smoothing method, Loess [@ref13]--[@ref14][@ref15], is applied to the data before the smoothed data is then fit to the Cole-Cole function where the Cole relaxation constant, *fc* is extracted. This parameter is then used to designate or classify data files cancer (CA) or benign (BE). A total of 360 files comprised on 180 CA and 180 BE files confirmed through pathology were randomly chosen from the database for inclusion as input to the neural networks. The dataset was then apportioned as follows; 70% of each CA and BE set (126 each) were set aside for training, 15% of each set (26 each) reserved for a validation set and the remaining 15% (26 each) was used as test sets that would not be introduced to the networks until the final stage.

The primary focus of this study is to distinguish cancer (inclusive of all types mentioned above) from benign normal tissue. The study did include tissue samples of fatty tissue and skin which contributed to confirmation that impedance data agreed with established and well documented impedance values.

One consideration to extract features for the neural network examined spectral features to discern malignant from normal tissue. [Fig. 3](#fig3){ref-type="fig"} and [Fig. 4](#fig4){ref-type="fig"} utilize analysis developed in [@ref16] show the viability and feasibility of Mel-frequency cepstral coefficients as neural network input, however, the statistical variability analysis explained later formed a solid basis for neural network input. FIGURE 3.Smooth Frequency Response windowed for 256x256 Mel filter bank interpolation for 4 Tissue types displaying sub-band power variability. FIGURE 4.Direct Cosine Transfrom of inverted cepstrals windowed for 256x256 Mel filter bank interpolation for 4 Tissue types displaying sub-band power variability.

An important aspect in the design of a neural network is judicious scrutiny of the datasets that will be used as input to the network. [Fig 5](#fig5){ref-type="fig"} depicts the 47 sample raw impedance datasets averaged over each frequency in the 1 Hz -- 32 MHz range. It can be observed that data in the imaginary part of $\documentclass[12pt]{minimal}
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\end{document}$ for CA and BE overlap at approximately 15 Hz and data at the higher frequencies around 5 MHz could also induce or contribute to error between the two datasets. FIGURE 5.47-sample dataset averages of 180 CA and 180 BE impedance files from 10 Hz -- 5 MHz displaying potential conflicts in data differentiation.

The decision to exclude lower frequency data was motivated by several works expounding the advantage of eliminating adverse electrode polarization effects that is particularly noticeable below 1 kHz [@ref17]--[@ref18][@ref19]. It was then necessary to consider excluding data above 3.2 MHz, [Fig. 6](#fig6){ref-type="fig"} displays the result of the modified 1e3 kHz -- 3.2 MHz datasets. The dashed vertical lines in [Fig. 6](#fig6){ref-type="fig"} demarcate the frequency range where the probability that the highest incidence of CA is expected based on our experimentation in [@ref2]. FIGURE 6.33-sample dataset averages of Z" for CA and BE from 10 Hz -- 4 MHz displaying the Cole frequency, fc and the frequency range of interest.

We consider 33 data samples in the frequency range 1 kHz to 3.2 MHz excluding potential error in the classification paradigm to address adverse polarization effects particularly noticeable below 1 kilohertz (kHz). [Fig 6](#fig6){ref-type="fig"} includes the Cole-Cole parameter, *fc*, for the averaged and smoothed Z"-CA and Z"-BE.

The vertical lines in [Fig. 6](#fig6){ref-type="fig"} demarcate the frequency range where the probability that the highest incidence of CA is expected based on our observations in [@ref2].

To confirm these observations a statistical analysis was performed. The first approach was a two-sided two-sample Kolmogorov-Smirnov test for $\documentclass[12pt]{minimal}
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\end{document}$ of the CA and BE averaged 47 and 33 sample datasets to determine the probability they are from the same distribution. The significantly small p-value for both datasets were an indication to reject the null hypothesis that the 2 datasets are from the same distribution and led to acceptance of the alternative hypothesis that the two datasets, CA and BE, are different. Another tool utilized to provide insight into the 47 and 33 sample datasets is the Kruskal-Wallis test, a nonparametric version of one-way ANOVA, and an extension of the Wilcoxon rank sum test. The test makes a rank comparison of the medians of the groups of data in question to determine if the samples come from the same dataset. A p-value of 0.999 for the Kruskal-Wallis $\documentclass[12pt]{minimal}
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\end{document}$ comparison and 0.987 for the Z" test indicate significant differences in both sets. An examination of one final comparison is a balanced one way ANOVA to ascertain some insight regarding the mean of the CA and BE datasets. [Fig. 6](#fig6){ref-type="fig"} displays the modified CA and BE datasets.

Results of the statistical analysis displayed in [Figs. 7](#fig7){ref-type="fig"}, [8](#fig8){ref-type="fig"}, and [9](#fig9){ref-type="fig"} for the modified datasets indicate that the CA and BE datasets display a significant amount of statistical variation that can be utilized as features that will contribute to a robust input data set to the neural networks. The results of the statistical analysis are summarized in [Table 1](#table1){ref-type="table"}. The high amount of outliers in the original 47 sample dataset can have deleterious effects on statistical analysis that could contribute an increased amount of error in the variance and bias and subsequently might adversely affect the regression algorithms utilized in the neural networks [@ref20]. TABLE 1Group Statistics for CA and BE DatasetsKruskal Wallis p-valueKW Result, Group medians equalKolmogoro v Smirnov p-valueKS Result, Group medians equalOne Way ANOVA p-valueANOVA Result Group means equalIntra-Group Correlation p-valueCorrelate d p-value \< 0.05Z' CA v Z' BE-470.9970NO0.0000NO0.0000NO0.0300YESZ"CA v Z"BE-470.0329YES0.0000NO0. 5819YES0.0000YESZ'CA v Z' BE-330.9873NO0.0000NO0. 0000NO0.4700NOZ"CA v Z"BE-330.9986NO0.0000NO0.0000NO0.1100NOZ'CA-47Z'CA-33Z'BE-47Z'BE-33Z"CA-47Z"CA-33Z"BE-47Z"BE-33Mean621.38669.50273.42268.47−36.1431 14−22.27−12.47VAR30714.463713. 572640.77378.5229731221188.025856.329.27STD175.2660.9451.3919.46172.4334.4776.533.04ANOVA OUTLIERS304182130 FIGURE 7.Kolmogorov-Smirnov nonparametric test of the comparison of the probability distribution for the 47 sample and 33 sample datasets. FIGURE 8.One way ANOVA for the 33 sample CA and BE datasets with a p-value of 0.00012 indicating significant difference in the datasets. FIGURE 9.Kruskal-Wallis nonparametric test displaying a rank comparison of the medians between the 33 samples BE and CA datasets.

Cross correlation and the results based on a 95% confidence interval in [Table 2](#table2){ref-type="table"} was also performed to confirm that there was a significant difference in the 47 sample and 33 sample datasets. A Receiver Operating Characteristic (ROC) curve was also utilized to discern the dataset integrity and is displayed in [Fig 10](#fig10){ref-type="fig"}.TABLE 2Correlation Statistics for CA and BENumber of SamplesCorrelationP ValueSignificantZ' CA v Z' BE470.31760.0296YESZ" -- CA v Z" -- BE470.66250.0000YESZ' -- CA v Z' BE330.16420.4654NOZ" -- CA v Z" -- BE330.34850.1119NO FIGURE 10.33-sample dataset averages of the imaginary CA and BE impedance files from 10 Hz -- 5 MHz displaying Fcole (*fc)* and the frequency range of interest.

III.. Neural Network Background {#sec3}
===============================

The use of artificial neural networks (ANN) as computational implementations of biological neural networks has been utilized to solve various machine learning tasks such as speech recognition [@ref16]. The supervised learning algorithm of a binary classifier utilizing a single layer or perceptron can be attributed to [@ref21]. Problems defined by [equation 4](#deqn4){ref-type="disp-formula"} can be addressed by a two dimensional perceptron.$$\documentclass[12pt]{minimal}
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Machine learning problems that involve vectors that are not linearly separable may require one or more additional hidden layers for increased computational capability are referred to as multilayered perceptrons (MLP) [@ref15], [@ref21]--[@ref22][@ref23][@ref24][@ref25][@ref26].

The six backpropagation MLPs chosen for this implementation are: 1)Gradient descent with momentum and adaptive learning rate backpropagation [@ref27].2)Levenberg-Marquardt backpropagation [@ref28].3)Resilient backpropagation [@ref29].4)Scaled conjugate gradient backpropagation [@ref30].5)Conjugate gradient backpropagation with Powell-Beale restarts [@ref31], [@ref32].6)Conjugate gradient backpropagation with Fletcher-Reeves updates [@ref33].

An important facet of neural network design is the development of a network that generalizes well to avoid overfitting. $\documentclass[12pt]{minimal}
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\end{document}$-fold cross validation is sometimes used to increase the likelihood that the random partition of data for training, validation, and test sets will provide better classification results providing a scheme where all the data is seen by the network in the test set once and all the data is trained at least $\documentclass[12pt]{minimal}
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Three of the neural network architectures, (4--6) employ conjugate gradient methods and are similar in their optimization approach to reset the search direction to the negative of the gradient but differ in how the reset point is determined. [@ref30]--\[35\]. Network architectures (1--3) vary in how the weights and bias are altered to achieve the same end result of minimization. All of the networks provide a common parameter to stop training early that helps avoid over fitting by monitoring validation data performance. Early stopping of training occurs when error on the validation data increases. [Table 3](#table3){ref-type="table"} lists a summary of some of the parameters that can be adjusted or initialized at the initial onset of training. The values in parenthesis are the actual number of parameters that can be changed. TABLE 3Correlation Statistics for CA and BENetwork Adjustable ParametersEPOCHSPerf GoalMax Validation FailsMin Perf GradientLinesearch routines (10)GD w/M (10)5001e-541e-5LM (7)401e-641e-6RP (9)3001e-541e-5SCG (7)3001e-641e-6Trust Region\*CGB (5)5001e-541e-5CharalambousCGF (5)5001e-641e-6Charalambous

An indication of neural network performance can include a linear regression to compare network output versus input for each phase of network performance as depicted in [Fig 11](#fig11){ref-type="fig"} of the Levenberg-Marquadt network. The correlation coefficient (R) based on the regression fit in this iteration indicated good performance in the training and validation phases (\~0.99 for each) and acceptable overall performance (\~0.99). This measure indicates that this network should reliably generalize test data newly introduced to the network. FIGURE 11.Linear regression fits with correlation coefficients for initial Levenberg-Marquadt neural network.

The process to iteratively and exhaustively test network performance after adjusting single parameters or experimentation with additional hidden layers led to reliable and robust final configurations for the six neural networks. [Table 3](#table3){ref-type="table"} summarizes individual adjustable network parameters generally common to each network with some algorithm specific parameters excluded.

IV.. Results {#sec4}
============

Six feedforward backpropagation neural networks were configured for this implementation using MathWorks © Matlab software \[34\] augmented with modified regression algorithms provided by the author in [@ref16]. Individual network architecture of each network is displayed in [Fig. 12](#fig12){ref-type="fig"}. Network implementation is discussed in [@ref15]. The final simulated test data results are summarized in [Table 4](#table4){ref-type="table"}. TABLE 4Simulation Results for Test DataOptimized Simulated Test Data Neural Network SensitivityCG POWELL-BEALELEVENBERG-MARQUARDTSCALED CGRESILIENT BPCG FLETCHER-REEVESVAR LR w/MOMENTUMTP272727272727FP000000TN272727272727FN000000Sensitivity (%)100.00100.00100.00100.00100.00100.00Specificity (%)100.00100.00100.00100.00100.00100.00PPV (%)100.00100.00100.00100.00100.00100.00NPV (%)100.00100.00100.00100.00100.00100.00 FIGURE 12.Neural network architectures depicting the number of hidden layers and neurons in each hidden layer for the six systems implemented.

The validation stage provided opportunity to adjust early stopping parameters of the neural networks such as regularization with retesting network performance. The test set led to robust results listed in [Table 4](#table4){ref-type="table"}.

Simulation results of the test data unseen by the networks until the final stage confirm that the networks generalized to data not seen previously by the networks. The possibility that sample files from the CA and BE datasets could be correlated providing similar output were addressed with software decision analysis based on network output. The simulation in [Fig. 13](#fig13){ref-type="fig"} depicts CGF and RP network response to random CA and BE test files. The output responses for the four neural networks not shown were similar. FIGURE 13.Simulation of CGF and RP neural network output response to correct classifications for BE and CA.

[Fig. 14](#fig14){ref-type="fig"} depicts trained network performance providing insight and indication of how fast some of the regression algorithms converge and how well the networks might generalize based on the slope of the mean squared error (mse). FIGURE 14.Network performance based on mean squared error.

[Fig. 15](#fig15){ref-type="fig"} displays the network output for one test file. Two network outputs are provided that compare the input data under test to an expected BE result and an expected CA result such that the network output is not absolute but relative to the ensuing comparative statistical analysis of each output response. FIGURE 15.Network performance based on mean squared error.

V.. Conclusions {#sec5}
===============

The incentive to improve cancer detection accuracy utilizing neural networks appears plausible based on the positive neural network implementation, Frequency dependent variation in impedance data appears to be a viable discerning feature for cancer classification. Data feature selection at the onset contributed to a successful network utilization. Systematic optimization of each neural network that differ in their approach to optimization contributed to highly predictive networks. The overall majority rule analysis calling for 4 of the 6 networks to agree seems prudent to ensure a high level of sensitivity and specificity. This algorithm can potentially be applied in real time immediately after an impedance based tissue scan and can be a useful tool particularly in environments lacking diagnostic apparatus or the requisite skilled practitioners needed to operate that equipment. The NovaScan device is currently being tested on excised squamous and basal cell carcinoma tissue. Successful completion of this feasibility study will lead to applying the technology directly to suspicious lesions on patients. The positive results thus far with breast tissue (N = 423) and limited skin tissue (N = 50) provide strong evidence that the self contained device consisting of a laptop computer, handheld Probe, and all requisite hardware and software providing an automated analysis is user friendly and highly portable and has the potential to be a beneficial tool in cancer detection. The definitive high level of classification accuracy, sensitivity, and specificity indicated by the results has the potential to dramatically increase and enhance clinical management flexibility by providing an effective patient tissue assessment tool in clinical or non-clinical environments. This device and software could help alleviate the challenges associated with tissue specimen interpretation and ease workflow integration by providing reliable, accurate, and consistent results. Specifically the technology could provide accurate prognostic value as a precursor to histologic or cytologic evaluation of biopsied tissue assisting in pathologic time management. It also has the potential to be utilized intraoperatively providing an oncologist or surgeon with valuable tissue assessment information.
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